Magnets in the gut: a new way to treat obesity and diabetes?

NCT ID NCT07085741

Ongoing Disease control Sponsor: GT Metabolic Solutions, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study is testing a new magnetic device that creates a shortcut in the digestive system to help people with obesity and type 2 diabetes lose weight and control blood sugar. Ten adults aged 18-65 with a BMI between 30 and 35 will have the device placed using a scope, without traditional surgery. The goal is to see if the procedure is safe and works as intended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MAGNET System, DI Biofragmentable (a magnetic device placed in the digestive tract to create a new connection between the duodenum and ileum)
What this could lead to: If it works, this could offer a less invasive, reversible alternative to traditional weight-loss surgery for controlling obesity and type 2 diabetes.
What could go wrong: This is a very small, early feasibility study with only 10 participants, so results may not apply to everyone. The device could fail to create a lasting connection, or may cause complications like blockage or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY TYPE 2 DIABETES

Contacts and locations

Locations

Corporativo Hospital Satelite

Naucalpan, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.